Substance / Medication

Terazosin hydrochloride

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

4 trials linked to this intervention

4
Total Trials
1
Recruiting
2
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Bioequivalence study of two formulations of terazosin hydrochloride capsule in healthy Chinese subjects under fasting and fed conditions.
Fan Lian-Lian, Li Mu-Peng, Wu Tong et al. · Int J Clin Pharmacol Ther · 2022
PMID: 34672254RCT
Acute generalized exanthematous pustulosis caused by terazosin hydrochloride.
Speck Laura M, Wilkerson Michael G, Perri Anthony J et al. · J Drugs Dermatol · 2008
PMID: 18459523Case Report
Bioequivalence Analysis of Terazosin Hydrochloride Tablets Based on Parallel Artificial Membrane Permeability Analysis.
Niu Jianzhao, Huang Hanhan, Ji Ming et al. · Pharmaceuticals (Basel) · 2024
PMID: 39204129OtherFull text (PMC)
Thermoanalytical investigation of terazosin hydrochloride.
Attia Ali Kamal, Mohamed Abdel-Moety Mona · Adv Pharm Bull · 2013
PMID: 24312828OtherFull text (PMC)
Identification, preparation, and characterization of several polymorphs and solvates of terazosin hydrochloride.
Bauer J, Morley J, Spanton S et al. · J Pharm Sci · 2006
PMID: 16493591Other
Transdermal iontophoresis delivery system for terazosin hydrochloride: anandstudy.
Jiang Changzhao, Jiang Xiumei, Wang Xiumin et al. · Drug Deliv · 2021
PMID: 33620010PreclinicalFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Terazosin hydrochloride (substance)
SNOMED CT
412519000
UMLS CUI
C0770137

Clinical Data

This intervention maps to 8 entities in the Healos knowledge graph.

4
Conditions
1
Biomarkers
2
Specialists
0
Symptoms
4
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.